BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36732025)

  • 21. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting MLL1-WDR5 interaction ameliorates neuropathic allodynia by attenuating histone H3 lysine 4 trimethylation-dependent spinal mGluR5 transcription.
    Lin TB; Lai CY; Hsieh MC; Ho YC; Wang HH; Yang PS; Cheng JK; Chen GD; Ng SC; Peng HY
    Pain; 2020 Sep; 161(9):1995-2009. PubMed ID: 32345914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WDR5 modulates cell motility and morphology and controls nuclear changes induced by a 3D environment.
    Wang P; Dreger M; Madrazo E; Williams CJ; Samaniego R; Hodson NW; Monroy F; Baena E; Sánchez-Mateos P; Hurlstone A; Redondo-Muñoz J
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):8581-8586. PubMed ID: 29987046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WDR5 positively regulates p53 stability by inhibiting p53 ubiquitination.
    Xie Q; Li Z; Chen J
    Biochem Biophys Res Commun; 2017 May; 487(2):333-338. PubMed ID: 28412363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1.
    Wang F; Zhang J; Ke X; Peng W; Zhao G; Peng S; Xu J; Xu B; Cui H
    Biochem Biophys Res Commun; 2020 Mar; 523(3):699-706. PubMed ID: 31948749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WD repeat-containing protein 5, a ubiquitously expressed histone methyltransferase adaptor protein, regulates smooth muscle cell-selective gene activation through interaction with pituitary homeobox 2.
    Gan Q; Thiébaud P; Thézé N; Jin L; Xu G; Grant P; Owens GK
    J Biol Chem; 2011 Jun; 286(24):21853-64. PubMed ID: 21531708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex.
    Ruthenburg AJ; Wang W; Graybosch DM; Li H; Allis CD; Patel DJ; Verdine GL
    Nat Struct Mol Biol; 2006 Aug; 13(8):704-12. PubMed ID: 16829959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Set1/MLL complex is indispensable for the transcriptional ability of heat shock transcription factor 2.
    Hayashida N
    Biochem Biophys Res Commun; 2015 Nov; 467(4):805-12. PubMed ID: 26478434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
    Sun Y; Bell JL; Carter D; Gherardi S; Poulos RC; Milazzo G; Wong JW; Al-Awar R; Tee AE; Liu PY; Liu B; Atmadibrata B; Wong M; Trahair T; Zhao Q; Shohet JM; Haupt Y; Schulte JH; Brown PJ; Arrowsmith CH; Vedadi M; MacKenzie KL; Hüttelmaier S; Perini G; Marshall GM; Braithwaite A; Liu T
    Cancer Res; 2015 Dec; 75(23):5143-54. PubMed ID: 26471359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.
    Imran A; Moyer BS; Canning AJ; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
    Biochem J; 2021 Jun; 478(11):2145-2161. PubMed ID: 34032265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse roles of WDR5-RbBP5-ASH2L-DPY30 (WRAD) complex in the functions of the SET1 histone methyltransferase family.
    Ali A; Tyagi S
    J Biosci; 2017 Mar; 42(1):155-159. PubMed ID: 28229975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression.
    Sun W; Guo F; Liu M
    J Cell Biochem; 2018 Apr; 119(4):3304-3316. PubMed ID: 29125890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WIN site inhibition disrupts a subset of WDR5 function.
    Siladi AJ; Wang J; Florian AC; Thomas LR; Creighton JH; Matlock BK; Flaherty DK; Lorey SL; Howard GC; Fesik SW; Weissmiller AM; Liu Q; Tansey WP
    Sci Rep; 2022 Feb; 12(1):1848. PubMed ID: 35115608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16
    Shimoda H; Doi S; Nakashima A; Sasaki K; Doi T; Masaki T
    Kidney Int; 2019 Nov; 96(5):1162-1175. PubMed ID: 31570196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex.
    Patel A; Vought VE; Dharmarajan V; Cosgrove MS
    J Biol Chem; 2011 Feb; 286(5):3359-69. PubMed ID: 21106533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
    Carugo A; Genovese G; Seth S; Nezi L; Rose JL; Bossi D; Cicalese A; Shah PK; Viale A; Pettazzoni PF; Akdemir KC; Bristow CA; Robinson FS; Tepper J; Sanchez N; Gupta S; Estecio MR; Giuliani V; Dellino GI; Riva L; Yao W; Di Francesco ME; Green T; D'Alesio C; Corti D; Kang Y; Jones P; Wang H; Fleming JB; Maitra A; Pelicci PG; Chin L; DePinho RA; Lanfrancone L; Heffernan TP; Draetta GF
    Cell Rep; 2016 Jun; 16(1):133-147. PubMed ID: 27320920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation.
    Cai WL; Chen JF; Chen H; Wingrove E; Kurley SJ; Chan LH; Zhang M; Arnal-Estape A; Zhao M; Balabaki A; Li W; Yu X; Krop ED; Dou Y; Liu Y; Jin J; Westbrook TF; Nguyen DX; Yan Q
    Elife; 2022 Aug; 11():. PubMed ID: 36043466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
    Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
    Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
    Ferrer-Diaz AI; Sinha G; Petryna A; Gonzalez-Bermejo R; Kenfack Y; Adetayo O; Patel SA; Hooda-Nehra A; Rameshwar P
    Cell Commun Signal; 2024 Feb; 22(1):119. PubMed ID: 38347590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.